Panagora Asset Management Inc Mersana Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 233,209 shares of MRSN stock, worth $167,910. This represents 0.0% of its overall portfolio holdings.

Number of Shares

233,209

Previous 236,225 1.28%

Holding current value

$167,910

Previous $474,000 7.17%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.23 - $2.25 $3,709 - $6,786	-3,016 Reduced 1.28%	233,209 $440,000
Q2 2024 Jul 29, 2024	BUY	$2.0 - $4.45 $366 - $814	183 Added 0.08%	236,225 $474,000
Q1 2024 May 07, 2024	SELL	$2.16 - $5.94 $33,134 - $91,119	-15,340 Reduced 6.1%	236,042 $1.06 Million
Q4 2023 Feb 08, 2024	SELL	$1.11 - $2.34 $456 - $961	-411 Reduced 0.16%	251,382 $583,000
Q3 2023 Oct 31, 2023	SELL	$1.06 - $3.91 $20,890 - $77,058	-19,708 Reduced 7.26%	251,793 $319,000
Q2 2023 Aug 11, 2023	BUY	$3.08 - $9.55 $170,336 - $528,153	55,304 Added 25.58%	271,501 $893,000
Q1 2023 May 11, 2023	BUY	$4.0 - $7.02 $100,936 - $177,142	25,234 Added 13.21%	216,197 $888,000
Q4 2022 Feb 13, 2023	BUY	$5.65 - $7.86 $23,650 - $32,901	4,186 Added 2.24%	190,963 $1.12 Million
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $864,777 - $1.49 Million	186,777 New	186,777 $1.26 Million
Q3 2021 Nov 10, 2021	SELL	$8.56 - $14.47 $1,977 - $3,342	-231 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$13.28 - $18.07 $235,746 - $320,778	-17,752 Reduced 98.72%	231 $3,000
Q1 2021 May 12, 2021	SELL	$15.31 - $26.52 $17,790 - $30,816	-1,162 Reduced 6.07%	17,983 $291,000
Q4 2020 Feb 10, 2021	BUY	$16.84 - $27.59 $19,568 - $32,059	1,162 Added 6.46%	19,145 $508,000
Q3 2020 Nov 13, 2020	SELL	$16.2 - $25.7 $1.51 Million - $2.39 Million	-93,171 Reduced 83.82%	17,983 $335,000
Q2 2020 Aug 12, 2020	SELL	$5.24 - $23.4 $278,264 - $1.24 Million	-53,104 Reduced 32.33%	111,154 $2.6 Million
Q1 2020 May 14, 2020	BUY	$4.41 - $9.28 $176,841 - $372,128	40,100 Added 32.3%	164,258 $957,000
Q4 2019 Feb 12, 2020	SELL	$1.45 - $6.73 $237,649 - $1.1 Million	-163,896 Reduced 56.9%	124,158 $711,000
Q3 2019 Nov 12, 2019	BUY	$1.54 - $4.2 $292,576 - $797,937	189,985 Added 193.73%	288,054 $455,000
Q2 2019 Aug 09, 2019	BUY	$3.84 - $6.4 $376,584 - $627,641	98,069 New	98,069 $397,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $70M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Mersana Therapeutics, Inc. Transaction History